Global  

FDA says a coronavirus vaccine would have to be at least 50% effective to be approved

USATODAY.com Tuesday, 30 June 2020 ()
A coronavirus vaccine would ideally be proven to be at least 50% effective for the Food and Drug Administration to approve it.
0
shares
ShareTweetSavePostSend
 
Video credit: Wochit - Published
News video: Coronavirus Vaccine: How Close Are We?

Coronavirus Vaccine: How Close Are We? 00:37

Researchers around the world are developing more than 145 vaccines against the coronavirus. 19 vaccines are in human trials but vaccines typically require years of research and testing. Scientists are racing to produce a safe and effective vaccine by next year, says Business Insider. The first...

You Might Like


💡 One News Page Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

Pfizer, BioNTech get vaccine 'fast track' from FDA [Video]

Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration, speeding up the regulatory review process. Jillian Kitchener has more.

Credit: Reuters - Politics    Duration: 01:02Published

FDA expands list of hand sanitizers to avoid due to methanol risk with more being recommended for recall

The FDA has expanded the number of hand sanitizers to avoid because they may contain the toxic substance methanol. Some have also been recalled.

USATODAY.com

Multiple brands of hand sanitizer recalled or should be avoided due to methanol risk, FDA says. See the list.

More than a dozen kinds of hand sanitizer should be avoided because they may contain methanol, a toxic substance when absorbed through skin.

USATODAY.com

FDA chief declines to back Trump’s ‘harmless’ COVID-19 claim

Washington: US Food and Drug Administration (FDA) Commissioner Stephen Hahn has declined to back President Donald Trump’s claim that 99 per cent of COVID-19..
WorldNews
Too soon to say if RNC will be safe -U.S. official [Video]

Too soon to say if RNC will be safe -U.S. official

Stephen Hahn, the Food and Drug Administration commissioner, said on Sunday it was "too early to tell" if it would be safe for people to attend August's Republican National Convention in Jacksonville, Florida. This report produced by Chris Dignam.

Credit: Reuters Studio    Duration: 01:43Published

Related videos from verified sources

As COVID Grows, California Shuts Down Again [Video]

As COVID Grows, California Shuts Down Again

California’s governor on Monday clamped new restrictions on businesses, reports HuffPost. The rules also include the state’s two largest school districts, Los Angeles and San Diego. He stated..

Credit: Wochit     Duration: 00:40Published
Is your mask effective? Here's a simple way to find out [Video]

Is your mask effective? Here's a simple way to find out

Face masks are required in public places in Nevada, but not all masks work the same. 13 Action News Reporter Marissa Kynaston has a simple way you can find out if your mask is effective.

Credit: KTNV Channel 13 Las Vegas     Duration: 01:29Published
Is a Cloth Mask Really an Effective Way to Stop the Spread of Coronavirus? [Video]

Is a Cloth Mask Really an Effective Way to Stop the Spread of Coronavirus?

Is a Cloth Mask Really an Effective Way to Stop the Spread of Coronavirus?

Credit: Cerise Media English     Duration: 03:29Published

Related news from verified sources

Acasti Pharma considering FDA's comments after receiving response to its CaPre TRILOGY trials briefing package

Acasti Pharma Inc (NASDAQ:ACST) (CVE:ACST) revealed Friday that it has received a written response from the US Food and Drug Administration (FDA) having...
Proactive Investors

CytoDyn asks regulator to review its application to license leronlimab for HIV treatment under priority designation

CytoDyn Inc (OTCQB:CYDY) said it has asked the US Food & drug Admi9nistration (FDA) to look at the group's application to license its leronlimab drug as a...
Proactive Investors

Azar, Trump Mislead on FDA’s Hydroxychloroquine Decision

Azar, Trump Mislead on FDA’s Hydroxychloroquine Decision
At the White House, the Health and Human Services secretary left the misleading impression that the FDA's decision to revoke its emergency use authorization of...
FactCheck.org


Tweets about this